Whole-genome sequencing in newborn screening programs

Science Translational Medicine

Volumn 6, Issue 229, 2014, Pages

  Knoppers, Bartha M ^a   Sénécal, Karine ^a   Borry, Pascal ^b   Avard, Denise ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CONFIDENTIALITY; COST CONTROL; DIAGNOSTIC ACCURACY; FOLLOW UP; GENE SEQUENCE; GENETIC SCREENING; GENOME ANALYSIS; HEALTH CARE POLICY; HEALTH IMPACT ASSESSMENT; HEALTH PROGRAM; HUMAN; MEDICAL INFORMATION; MEDICAL RECORD; MEDICAL SOCIETY; NEWBORN SCREENING; NOTE; ORGANIZATIONAL DEVELOPMENT; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; OUTCOME ASSESSMENT; PARENTAL ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; RISK ASSESSMENT; RISK FACTOR;

GENOME, HUMAN; HEALTH POLICY; HUMANS; INFANT, NEWBORN; MUTATION; NEONATAL SCREENING; SEQUENCE ANALYSIS, DNA;

EID: 84899127625     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008494     Document Type: Note

References (34)

1. A. E. Hall, S. Chowdhury, N. Pashayan, N. Hallowell, P. Pharoah, H. Burton, What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer? J. Med. Ethics 40, 163-167 (2014).
2. Centers for Disease Control and Prevention, "Ten Great Public Health Achievements-United States, 2001-2010," Morbidity and Mortality Weekly Report (Centers for Disease Control and Prevention, Washington, DC, 2011); published online (www.cdc.gov/mmwr/pdf/wk/mm6019.pdf).
3. K. Wilson, S. Kennedy, B. Potter, M. Gerghty, P. Charkraborty, Developing a national newborn screening strategy for Canada. Health Law Rev. 18, 31-39 (2010).
4. N. J. Kerruish, S. P. Robertson, Newborn screening: New developments, new dilemmas. J. Med. Ethics 31, 393-398 (2005).
5. C. Curtin, ASHG panelists discuss interest in sequencing-based newborn screening. GenomeWeb (2013).
6. National Institutes of Health, NIH Program Explores the Use of Genomic Sequencing in Newborn Healthcare (2013); published online www.nih.gov/news/ health/sep2013/nhgri-04.htm).
7. C. Wright, H. Burton, A. Hall, S. Moorthie, A. Pokorska-Bocci, G. Sagoo, S. Sanderson, R. Skinner, Next Steps in the Sequence: The Implications of Whole Genome Sequencing for Health in the UK (PHG Foundation, Cambridge, UK, 2011).
8. C. J. Saunders, N. A. Miller, S. E. Soden, D. L. Dinwiddie, A. Noll, N. A. Alnadi, N. Andraws, M. L. Patterson, L. A. Krivohlavek, J. Fellis, S. Humphray, P. Saffrey, Z. Kingsbury, J. C. Weir, J. Betley, R. J. Grocock, E. H. Margulies, E. G. Farrow, M. Artman, N. P. Safina, J. E. Petrikin, K. P. Hall, S. F. Kingsmore, Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci. Transl. Med. 4, 154ra135 (2012).
9. M. H. Lewis, A. Goldenberg, R. Anderson, E. Rothwell, J. Botkin, State laws regarding the retention and use of residual newborn screening blood samples. Pediatrics 127, 703-712 (2011).
10. A. K. Daly, Genome-wide association studies in pharmacogenomics. Nat. Rev. Genet. 11, 241-246 (2010).
11. J. P. Evans, J. S. Berg, A. F. Olshan, T. Magnuson, B. K. Rimer, We screen newborns, don't we? Realizing the promise of public health genomics. Genet. Med. 15, 332-334 (2013).
12. Human Genetic Commission, Profiling the Newborn: A Prospective Gene Technology (Human Genetic Commission, UK, 2005).
13. B. A. Tarini, A. J. Goldenberg, Ethical issues with newborn screening in the genomics era. Annu. Rev. Genomics Hum. Genet. 13, 381-393 (2012).
14. American Academy of Pediatrics & American College of Medical Genetics, Policy statement: Ethical and policy issues in genetic testing and screening of children. Pediatrics, published online 21 February 2013 (10.1542/peds.2012-3680).
15. L. F. Ross, H. M. Saal, K. L. David, R. R. Anderson, American Academy of Pediatrics: American College of Medical Genetics and Genomics, Technical report: Ethical and policy issues in genetic testing and screening of children. Genet. Med. 15, 234-245 (2013).
16. ACMG Board of Directors, Points to consider in the clinical application of genomic sequencing. Genet. Med. 14, 759-761 (2012).
17. ACMG Board of Directors, Points to consider for informed consent for genome/exome sequencing. Genet. Med. 15, 748-749 (2013).
18. C. G. van El, M. C. Cornel, P. Borry, R. J. Hastings, F. Fellmann, S. V. Hodgson, H. C. Howard, A. Cambon-Thomsen, B. M. Knoppers, H. Meijers-Heijboer, H. Scheffer, L. Tranebjaerg, W. Dondorp, G. M. de Wert, ESHG Public and Professional Policy Committee, Whole-genome sequencing in health care: Recommendations of the European Society of Human Genetics. Eur. J. Hum. Genet. 21 (suppl. 1), S1-S5 (2013).
19. PHG Foundation, Stratified Screening for Cancer - Recommendations and Analysis from the COGS Project (PHG Foundation, Cambridge, UK, 2014).
20. R. C. Green, J. S. Berg, W. W. Grody, S. S. Kalia, B. R. Korf, C. L. Martin, A. L. McGuire, R. L. Nussbaum, J. M. O'Daniel, K. E. Ormond, H. L. Rehm, M. S. Watson, M. S. Williams, L. G. Biesecker, ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 15, 565-574 (2013).
21. B. M. Knoppers, D. Avard, K. Sénécal, M. Zawati, P3G International Paediatrics Platform, Return of whole-genome sequencing results in paediatric research: A statement of the P3G international paediatrics platform. Eur. J. Hum. Genet. 176, 1-3 (2013).
22. C. H. Wade, B. A. Tarini, B. S. Wilfond, Growing up in the genomic era: Implications of whole-genome sequencing for children, families, and pediatric practice. Annu. Rev. Genomics Hum. Genet. 14, 535-555 (2013).
23. W. J. Dondorp, G. M. de Wert, The 'thousand-dollar genome': An ethical exploration. Eur. J. Hum. Genet. 21, (Suppl 1), S6-S26 (2013).
24. M. Cornel, T. Rigter, S. Weinreich, P. Burgard, G. Hoffmann, M. Lindner, G. Loeber, K. Rupp, D. Taruscio, L. Vittozzi, Newborn screening in Europe: Expert opinion document. Eur. J. Hum. Genet. 22, 12-17 (2014).
25. T. Caulfield, J. Evans, A. McGuire, C. McCabe, T. Bubela, R. Cook-Deegan, J. Fishman, S. Hogarth, F. A. Miller, V. Ravitsky, B. Biesecker, P. Borry, M. K. Cho, J. C. Carroll, H. Etchegary, Y. Joly, K. Kato, S. S. Lee, K. Rothenberg, P. Sankar, M. J. Szego, P. Ossorio, D. Pullman, F. Rousseau, W. J. Ungar, B. Wilson, Reflections on the cost of "low-cost" whole genome sequencing: Framing the health policy debate. PLOS Biol. 11, e1001699 (2013).
26. United Nations Educational, Scientific and Cultural Organization, Universal Declaration on the Human Genome and Human Rights (1997); http://portal.unesco.org/en/ev.php-URL-ID=13177&URL-DO=DO-TOPIC&URL- SECTION=201.html.
27. S. Suther, P. Goodson, Barriers to the provision of genetic services by primary care physicians: A systematic review of the literature. Genet. Med. 5, 70-76 (2003).
28. A. J. Goldenberg, D. S. Dodson, M. M. Davis, B. A. Tarini, Parents' interest in whole-genome sequencing of newborns. Genet. Med. 16, 78-84 (2014).
29. Y. Bombard, F. A. Miller, R. Z. Hayeems, C. Barg, C. Cressman, J. C. Carroll, B. J. Wilson, J. Little, D. Avard, M. Painter-Main, J. Allanson, Y. Guiguere, P. Chakraborty, Public views on participating in newborn screening using genome sequencing. Eur. J. Hum. Genet. (2014). 10.1038/ejhg.2014.22
30. A. J. Goldenberg, R. R. Sharp, The ethical hazards and programmatic challenges of genomic newborn screening. J. Am. Med. Assoc. 307, 461-462 (2012).
31. E. W. Clayton, A. L. McGuire, The legal risks of returning results of genomics research. Genet. Med. 14, 473-477 (2012).
32. W. G. Feero, Clinical application of whole-genome sequencing: proceed with care. JAMA 311, 1017-1019 (2014).
33. B. M. Knoppers, D. Avard, K. Sénécal, Newborn screening programmes: Emerging biobanks? Norsk Epidemiologi 21, 163-168 (2012).
34. F. S. Collins, The Language of Life: DNA and the Revolution in Personalized Medicine (Harper Perennial, New York, 2010).